Skip to content
Axcess News – Lifestyle
Author:
Appili Therapeutics Inc.
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
July 3, 2026
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
June 26, 2026
Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement
March 4, 2026